SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

OBJECTIVES: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) produced good tumor response in cases with lung squamous cell carcinoma, one of the most difficult cancers to treat. Secreted protein acidic and rich in cysteine (SPARC) binds to albumin, suggesting that SPARC plays an important role...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiya, Kazutoshi, Nakamura, Tomomi, Nakashima, Chiho, Takahashi, Koichiro, Umeguchi, Hitomi, Watanabe, Naomi, Sato, Akemi, Takeda, Yuji, Kimura, Shinya, Sueoka-Aragane, Naoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089830/
https://www.ncbi.nlm.nih.gov/pubmed/27822069
http://dx.doi.org/10.2147/OTT.S114492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089830/
https://www.ncbi.nlm.nih.gov/pubmed/27822069
http://dx.doi.org/10.2147/OTT.S114492

Ejemplares similares